Sofosbuvir/velpatasvir fixed dose combination for 12 weeks in patients co-infected with HCV and HIV-1: the phase

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Braeu, N; Wyles, D; Kottilil, S; Darr, E; Workowski, K; Luetkemeyer, A; Adeyemi, O; Ruane, P; Doehle, B; Huang, KC; Osinusi, A; McNally, J; Natha, M; Guion, M; McLean, T; Brainard, DM; McHutchison, JG; Naggie, S; Sulkowski, M

Published Date

  • July 2016

Published In

Volume / Issue

  • 19 /

International Standard Serial Number (ISSN)

  • 1758-2652